See more : Photocure ASA (0IMT.L) Income Statement Analysis – Financial Results
Complete financial analysis of Imaspro Corporation Berhad (7222.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Imaspro Corporation Berhad, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Big Lots, Inc. (BIG) Income Statement Analysis – Financial Results
- Beryl Securities Limited (BERYLSE.BO) Income Statement Analysis – Financial Results
- Titan Kogyo, Ltd. (4098.T) Income Statement Analysis – Financial Results
- TransFin-M OJSC (TRFM.ME) Income Statement Analysis – Financial Results
- Dreambed Co.,Ltd. (7791.T) Income Statement Analysis – Financial Results
Imaspro Corporation Berhad (7222.KL)
About Imaspro Corporation Berhad
Imaspro Corporation Berhad, an investment holding company, engages in the manufacture and distribution of agrochemicals, public health, and environmental science products in Malaysia, Indonesia, Russia, the Philippines, Australia, Cambodia, China, Lebanon, Singapore, Taiwan, New Zealand, and Vietnam. The company's products include herbicides, insecticides, fungicides, specialty products, plant micronutrients, fertilizers, public health products, pest control products, wood preservatives, and other related products. It is also involved in the provision of research, development, and training services related to pesticides and agrochemicals; distribution and agency of pesticides and other agrochemicals; and manufacturing and trading of mosquito coils, disinfectants, and household insecticides, as well as trading of pesticides and other agrochemicals. The company was incorporated in 2004 and is headquartered in Klang, Malaysia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 51.47M | 50.14M | 76.61M | 56.99M | 66.52M |
| Cost of Revenue | 34.82M | 39.95M | 58.01M | 41.02M | 53.41M |
| Gross Profit | 16.64M | 10.19M | 18.59M | 15.97M | 13.11M |
| Gross Profit Ratio | 32.34% | 20.32% | 24.27% | 28.02% | 19.71% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.97M | 7.91M | 6.95M | 7.20M | 7.34M |
| Selling & Marketing | 855.73K | 523.92K | 931.21K | 641.54K | 785.46K |
| SG&A | 9.82M | 8.43M | 7.88M | 7.84M | 8.12M |
| Other Expenses | -700.05K | 262.00K | 232.00K | 69.48K | 204.60K |
| Operating Expenses | 9.12M | 10.44M | 9.17M | 9.39M | 9.92M |
| Cost & Expenses | 43.94M | 50.39M | 67.18M | 50.41M | 63.33M |
| Interest Income | 1.62M | 692.32K | 350.77K | 473.62K | 596.97K |
| Interest Expense | 109.66K | 111.65K | 104.84K | 140.32K | 208.59K |
| Depreciation & Amortization | 1.44M | 1.48M | 1.49M | 1.55M | 1.70M |
| EBITDA | 8.96M | 4.36M | 17.23M | 9.66M | 6.67M |
| EBITDA Ratio | 17.41% | 7.81% | 16.52% | 16.84% | 9.91% |
| Operating Income | 7.52M | 2.64M | 15.74M | 8.11M | 4.98M |
| Operating Income Ratio | 14.62% | 5.26% | 20.55% | 14.23% | 7.48% |
| Total Other Income/Expenses | -109.66K | -111.65K | -104.84K | -140.32K | -208.59K |
| Income Before Tax | 7.41M | 2.53M | 15.64M | 7.97M | 4.77M |
| Income Before Tax Ratio | 14.40% | 5.04% | 20.41% | 13.98% | 7.17% |
| Income Tax Expense | 2.30M | 972.72K | 3.12M | 1.89M | 1.65M |
| Net Income | 5.12M | 1.80M | 2.19M | 1.82M | 1.11M |
| Net Income Ratio | 9.94% | 3.58% | 2.85% | 3.19% | 1.66% |
| EPS | 0.06 | 0.02 | 0.03 | 0.02 | 0.01 |
| EPS Diluted | 0.06 | 0.02 | 0.03 | 0.02 | 0.01 |
| Weighted Avg Shares Out | 80.00M | 80.00M | 80.00M | 80.00M | 80.00M |
| Weighted Avg Shares Out (Dil) | 80.00M | 80.00M | 80.00M | 80.00M | 80.00M |
Source: https://incomestatements.info
Category: Stock Reports